Xilio therapeutics to present at td cowen 45th annual health care conference

Waltham, mass., feb. 24, 2025 (globe newswire) -- xilio therapeutics, inc. (nasdaq: xlo), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that renÉ russo, pharm.d., president and chief executive officer, will participate in a fireside chat at the td cowen 45th annual health care conference on monday, march 3, 2025 at 9:50 am est.
COWN Ratings Summary
COWN Quant Ranking